OTCM
CZGZF
Market cap1.20bUSD
Dec 04, Last price
35.80USD
1D
0.00%
1Q
6.39%
IPO
110.50%
Name
Colt CZ Group SE
Chart & Performance
P/E
24.79
P/S
1.14
EPS
30.03
Div Yield, %
3.59%
Shrs. gr., 5y
9.74%
Rev. gr., 5y
30.69%
Revenues
22.71b
+52.90%
Net income
1.04b
-48.86%
CFO
2.67b
+88.97%
Dividend
Jul 03, 20241.28688 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Colt CZ Group SE, together with its subsidiaries, engages in the production, purchase, and sale of firearms, ammunition products, and tactical accessories in the Czech Republic, the United States, rest of Europe, Africa, Asia, and internationally. Its firearms include pistols, revolvers, rifles, submachine guns, grenade launchers, machine guns, sniper rifles, shotguns, and centrefire rifles; and components for firearms comprising sights, optical mounting solutions, triggers, stocks, grips, and spare parts. The company also offers tactical and ballistic equipment, such as ballistic vests, helmets and other protection products, combat uniforms, and backpacks, as well as firearms accessories consisting of handgun holsters, magazine pouches, and slings. In addition, it is also involved in the lease of real estate properties; and trade of military materials. The company markets and sells its products under the Colt, CZ (Ceská zbrojovka), CZ-USA, Colt Canada, Dan Wesson, Brno Rifles, and 4M Systems brands. It sells its products for armed forces, military and law enforcement, personal defense, hunting, sport shooting, and other civilian uses. The company was formerly known as CZG - Ceská zbrojovka Group SE and changed its name to Colt CZ Group SE in April 2022. The company was founded in 1936 and is headquartered in Prague, the Czech Republic. Colt CZ Group SE is a subsidiary of Ceska Zbrojovka Partners SE.
Valuation
Title CZK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||